Randomized controlled trial of feeding a concentrated formula to infants born to women infected by human immunodeficiency virus

Harland S. Winter, James M. Oleske, Michael D. Hughes, Ross E. McKinney, Carol Elgie, Christine Powell, Lynette Purdue, Ana M. Puga, Eleanor Jimenez, Gwendolyn B Scott, Maria Leticia Santos Cruz, Jack Moye

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective:: We tested the hypothesis that concentrated formula (CF) begun within the first 2 weeks of life increases growth in infants born to human immunodeficiency virus (HIV)-infected mothers. Materials and Methods:: HIV-exposed infants from the United States, the Bahamas, and Brazil were randomized in a double-blind, controlled trial to receive either a CF (87 kcal/100 mL [26 kcal/oz]) or a standard formula (SF; 67 kcal/100 mL [20 kcal/oz]) for 8 weeks. This article presents results for infants who were not determined to be HIV infected based on testing at 4 weeks. Primary outcomes were safety, tolerability, and growth in weight and length. Results:: Two thousand ninety-seven infants were enrolled, of whom 1998 were uninfected and had study formula dispensed. At weeks 4 and 8, uninfected infants receiving CF showed higher energy intake than those who were receiving SF (P < 0.001). By week 8, uninfected infants assigned to CF weighed more than infants receiving SF. There were no consistent differences in measures of tolerability, and rates of discontinuation or perceived formula intolerance were similar between treatment groups. Conclusions:: A CF is well tolerated and results in increased weight gain compared with SF. Until the HIV status of an infant is reliably determined, early introduction of a CF in HIV-exposed children may have beneficial effects on growth. The role of early nutritional intervention remains to be determined for individuals living in countries with endemic malnutrition for whom formula feeding is a viable option.

Original languageEnglish
Pages (from-to)222-232
Number of pages11
JournalJournal of Pediatric Gastroenterology and Nutrition
Volume49
Issue number2
DOIs
StatePublished - Aug 1 2009

Fingerprint

Infant Formula
Randomized Controlled Trials
HIV
Bahamas
Growth
Energy Intake
Malnutrition
Weight Gain
Brazil
Mothers
Safety
Weights and Measures

Keywords

  • AIDS
  • HIV
  • Nutrition

ASJC Scopus subject areas

  • Gastroenterology
  • Pediatrics, Perinatology, and Child Health

Cite this

Randomized controlled trial of feeding a concentrated formula to infants born to women infected by human immunodeficiency virus. / Winter, Harland S.; Oleske, James M.; Hughes, Michael D.; McKinney, Ross E.; Elgie, Carol; Powell, Christine; Purdue, Lynette; Puga, Ana M.; Jimenez, Eleanor; Scott, Gwendolyn B; Cruz, Maria Leticia Santos; Moye, Jack.

In: Journal of Pediatric Gastroenterology and Nutrition, Vol. 49, No. 2, 01.08.2009, p. 222-232.

Research output: Contribution to journalArticle

Winter, HS, Oleske, JM, Hughes, MD, McKinney, RE, Elgie, C, Powell, C, Purdue, L, Puga, AM, Jimenez, E, Scott, GB, Cruz, MLS & Moye, J 2009, 'Randomized controlled trial of feeding a concentrated formula to infants born to women infected by human immunodeficiency virus', Journal of Pediatric Gastroenterology and Nutrition, vol. 49, no. 2, pp. 222-232. https://doi.org/10.1097/MPG.0b013e3181928937
Winter, Harland S. ; Oleske, James M. ; Hughes, Michael D. ; McKinney, Ross E. ; Elgie, Carol ; Powell, Christine ; Purdue, Lynette ; Puga, Ana M. ; Jimenez, Eleanor ; Scott, Gwendolyn B ; Cruz, Maria Leticia Santos ; Moye, Jack. / Randomized controlled trial of feeding a concentrated formula to infants born to women infected by human immunodeficiency virus. In: Journal of Pediatric Gastroenterology and Nutrition. 2009 ; Vol. 49, No. 2. pp. 222-232.
@article{6642ae5c14964cd195d84efd2ae3d978,
title = "Randomized controlled trial of feeding a concentrated formula to infants born to women infected by human immunodeficiency virus",
abstract = "Objective:: We tested the hypothesis that concentrated formula (CF) begun within the first 2 weeks of life increases growth in infants born to human immunodeficiency virus (HIV)-infected mothers. Materials and Methods:: HIV-exposed infants from the United States, the Bahamas, and Brazil were randomized in a double-blind, controlled trial to receive either a CF (87 kcal/100 mL [26 kcal/oz]) or a standard formula (SF; 67 kcal/100 mL [20 kcal/oz]) for 8 weeks. This article presents results for infants who were not determined to be HIV infected based on testing at 4 weeks. Primary outcomes were safety, tolerability, and growth in weight and length. Results:: Two thousand ninety-seven infants were enrolled, of whom 1998 were uninfected and had study formula dispensed. At weeks 4 and 8, uninfected infants receiving CF showed higher energy intake than those who were receiving SF (P < 0.001). By week 8, uninfected infants assigned to CF weighed more than infants receiving SF. There were no consistent differences in measures of tolerability, and rates of discontinuation or perceived formula intolerance were similar between treatment groups. Conclusions:: A CF is well tolerated and results in increased weight gain compared with SF. Until the HIV status of an infant is reliably determined, early introduction of a CF in HIV-exposed children may have beneficial effects on growth. The role of early nutritional intervention remains to be determined for individuals living in countries with endemic malnutrition for whom formula feeding is a viable option.",
keywords = "AIDS, HIV, Nutrition",
author = "Winter, {Harland S.} and Oleske, {James M.} and Hughes, {Michael D.} and McKinney, {Ross E.} and Carol Elgie and Christine Powell and Lynette Purdue and Puga, {Ana M.} and Eleanor Jimenez and Scott, {Gwendolyn B} and Cruz, {Maria Leticia Santos} and Jack Moye",
year = "2009",
month = "8",
day = "1",
doi = "10.1097/MPG.0b013e3181928937",
language = "English",
volume = "49",
pages = "222--232",
journal = "Journal of Pediatric Gastroenterology and Nutrition",
issn = "0277-2116",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Randomized controlled trial of feeding a concentrated formula to infants born to women infected by human immunodeficiency virus

AU - Winter, Harland S.

AU - Oleske, James M.

AU - Hughes, Michael D.

AU - McKinney, Ross E.

AU - Elgie, Carol

AU - Powell, Christine

AU - Purdue, Lynette

AU - Puga, Ana M.

AU - Jimenez, Eleanor

AU - Scott, Gwendolyn B

AU - Cruz, Maria Leticia Santos

AU - Moye, Jack

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Objective:: We tested the hypothesis that concentrated formula (CF) begun within the first 2 weeks of life increases growth in infants born to human immunodeficiency virus (HIV)-infected mothers. Materials and Methods:: HIV-exposed infants from the United States, the Bahamas, and Brazil were randomized in a double-blind, controlled trial to receive either a CF (87 kcal/100 mL [26 kcal/oz]) or a standard formula (SF; 67 kcal/100 mL [20 kcal/oz]) for 8 weeks. This article presents results for infants who were not determined to be HIV infected based on testing at 4 weeks. Primary outcomes were safety, tolerability, and growth in weight and length. Results:: Two thousand ninety-seven infants were enrolled, of whom 1998 were uninfected and had study formula dispensed. At weeks 4 and 8, uninfected infants receiving CF showed higher energy intake than those who were receiving SF (P < 0.001). By week 8, uninfected infants assigned to CF weighed more than infants receiving SF. There were no consistent differences in measures of tolerability, and rates of discontinuation or perceived formula intolerance were similar between treatment groups. Conclusions:: A CF is well tolerated and results in increased weight gain compared with SF. Until the HIV status of an infant is reliably determined, early introduction of a CF in HIV-exposed children may have beneficial effects on growth. The role of early nutritional intervention remains to be determined for individuals living in countries with endemic malnutrition for whom formula feeding is a viable option.

AB - Objective:: We tested the hypothesis that concentrated formula (CF) begun within the first 2 weeks of life increases growth in infants born to human immunodeficiency virus (HIV)-infected mothers. Materials and Methods:: HIV-exposed infants from the United States, the Bahamas, and Brazil were randomized in a double-blind, controlled trial to receive either a CF (87 kcal/100 mL [26 kcal/oz]) or a standard formula (SF; 67 kcal/100 mL [20 kcal/oz]) for 8 weeks. This article presents results for infants who were not determined to be HIV infected based on testing at 4 weeks. Primary outcomes were safety, tolerability, and growth in weight and length. Results:: Two thousand ninety-seven infants were enrolled, of whom 1998 were uninfected and had study formula dispensed. At weeks 4 and 8, uninfected infants receiving CF showed higher energy intake than those who were receiving SF (P < 0.001). By week 8, uninfected infants assigned to CF weighed more than infants receiving SF. There were no consistent differences in measures of tolerability, and rates of discontinuation or perceived formula intolerance were similar between treatment groups. Conclusions:: A CF is well tolerated and results in increased weight gain compared with SF. Until the HIV status of an infant is reliably determined, early introduction of a CF in HIV-exposed children may have beneficial effects on growth. The role of early nutritional intervention remains to be determined for individuals living in countries with endemic malnutrition for whom formula feeding is a viable option.

KW - AIDS

KW - HIV

KW - Nutrition

UR - http://www.scopus.com/inward/record.url?scp=68949148553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68949148553&partnerID=8YFLogxK

U2 - 10.1097/MPG.0b013e3181928937

DO - 10.1097/MPG.0b013e3181928937

M3 - Article

C2 - 19543114

AN - SCOPUS:68949148553

VL - 49

SP - 222

EP - 232

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

SN - 0277-2116

IS - 2

ER -